Your browser doesn't support javascript.
loading
Industry and regulatory performance in 2012: a year in review.
Dowden, H M; Jahn, R; Catka, T; Jonsson, A; Michael, E; Miwa, Y; Zinkand, W.
Affiliation
  • Dowden HM; Strategy Portfolio & Performance, AstraZeneca, Wilmington, Delaware, USA. helen.dowden@astrazeneca.com
Clin Pharmacol Ther ; 94(3): 359-66, 2013 Sep.
Article in En | MEDLINE | ID: mdl-23657160
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval / Drug Industry Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Pharmacol Ther Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval / Drug Industry Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Pharmacol Ther Year: 2013 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos